Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02406508
Title Sequential Melphalan for Use With Hepatic Delivery System Treatment Followed by Sorafenib in Patients With Unresectable HCC
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Delcath Systems Inc.
Age Groups: adult
Covered Countries USA

No variant requirements are available.